Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06289192 · ClinicalTrials.gov registry record · Phase 4
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT06289192: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT06289192 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06289192, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker (CHW) support and navigation to lung cancer screening in low-income housing units in Baltimore, the investigators propose to collect data on intervention acceptability and feasibility among individuals in public housing as well as feedback on use of shared decision making when referring for low-dose chest CT (LDCT). The investigators will conduct a feasibility pilot study of a virtual counselor plus community health worker intervention. With a sample of participants from public housing units (N=15), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month and 3 months. At the end of three months, the investigators will conduct follow up interviews with a subset of pilot participants to collect qualitative data on intervention acceptability. Based on this information, the investigators will make iterative improvements to the combined intervention.
Interventions
- OTHER Community Health Worker
- DRUG Nicotine Replacement Product
- BEHAVIORAL C-Raven Virtual Tobacco Cessation Counseling
- OTHER Lung Cancer Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2024-08-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06289192
The ClinicalTrials.gov registry entry for NCT06289192 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Community Health Worker is the first listed.
NCT06289192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06289192 about?
NCT06289192 is a clinical study titled "Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community". To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker (CHW) support and navigation to lung cancer screening in low-income housing units in Baltimore, the investigators propose to collect data on int...
What is the current status of trial NCT06289192?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2024-04-30. Estimated completion is 2024-08-27.
What interventions are being tested in trial NCT06289192?
The interventions under investigation include: Community Health Worker (OTHER), Nicotine Replacement Product (DRUG), C-Raven Virtual Tobacco Cessation Counseling (BEHAVIORAL), Lung Cancer Screening (OTHER).
Who is sponsoring clinical trial NCT06289192?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.